Kahn Brothers Group Inc – GSK history
- Issuer:
- GSK PLC ADR
- Quarters tracked:
- 14 (Q4 2023 → Q1 2026)
- Current shares:
- 160,982
- Current value:
- $8.88M
- Peak shares:
- 1,259,482 (Q4 2023)
- Overall change:
- -87%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 160,982 | $8.88M | $55.19 | -17,714 | -10% |
| Q4 2025 | 178,696 | $8.76M | $49.04 | -82,141 | -31% |
| Q3 2025 | 260,837 | $11.26B | $43160.00 | 0 | 0% |
| Q3 2025 | 260,837 | $11.26M | $43.16 | -399,035 | -60% |
| Q2 2025 | 659,872 | $25.34M | $38.40 | 0 | 0% |
| Q2 2025 | 659,872 | $25.34B | $38400.00 | -162,355 | -20% |
| Q1 2025 | 822,227 | $31.85M | $38.74 | 0 | 0% |
| Q1 2025 | 822,227 | $31.85B | $38739.47 | -62,481 | -7% |
| Q4 2024 | 884,708 | $29.92M | $33.82 | 0 | 0% |
| Q4 2024 | 884,708 | $29.92B | $33820.34 | -174,124 | -16% |
| Q3 2024 | 1,058,832 | $43.29B | $40880.02 | -182,429 | -15% |
| Q2 2024 | 1,241,261 | $47.79B | $38499.92 | -12,383 | -1% |
| Q1 2024 | 1,253,644 | $53.74B | $42869.73 | -5,838 | 0% |
| Q4 2023 | 1,259,482 | $46.68B | $37060.11 | — | NEW |